KAM W. SIU,ANDREW P. CREW,HANQING DONG,CATERINA FERRARO,DAN SHERMAN
申请号：
PT11794899
公开号：
PT2646448T
申请日:
2011.11.29
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.
